Bulexin 8 mg / 2 mg sublingual tablets
- Licence status
- Active substances
- Buprenorphine hydrochloride , Naloxone hydrochloride dihydrate
- Dosage Form
- Sublingual tablet
- Licence number
- PA0281/267/003
- Licence holder
- Pinewood Laboratories Ltd
Product documents
Licence information
- ATC code
- N07BC51 buprenorphine, combinations
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2). This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 2017.
- Marketing availability
- Not marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 20/12/2024